SMTL ID : 5g1n.2 (1 other biounit)

Aspartate transcarbamoylase domain of human CAD bound to PALA

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

homo-trimer

Ligands

3 x PAL: N-(PHOSPHONACETYL)-L-ASPARTIC ACID(Non-covalent)

PAL.1: 14 residues within 4Å: Chain A: S.62, T.63, R.64, T.65, R.113, H.141, Q.144, R.174, R.235, Q.237, M.274, P.275 Chain B: S.89, K.92 20 PLIP interactions: 15 interactions with chain A, 5 interactions with chain B Hydrogen bonds: A:S.62, A:T.63, A:R.64, A:R.64, A:T.65, A:T.65, A:R.113, A:R.113, A:Q.144, A:Q.237, A:M.274, B:S.89, B:S.89, B:K.92 Salt bridges: A:R.113, A:H.141, A:R.174, A:R.235, B:K.92, B:K.92 PAL.2: 15 residues within 4Å: Chain B: S.62, T.63, R.64, T.65, R.113, H.141, Q.144, R.174, T.175, R.235, Q.237, P.273, M.274 Chain C: S.89, K.92 20 PLIP interactions: 3 interactions with chain C, 17 interactions with chain B Hydrogen bonds: C:S.89, B:S.62, B:S.62, B:T.63, B:R.64, B:T.65, B:R.113, B:R.113, B:Q.237, B:M.274 Salt bridges: C:K.92, C:K.92, B:R.113, B:H.141, B:R.174, B:R.235 Hydrophobic interactions: B:T.175, B:P.273 Water bridges: B:R.235, B:R.235 PAL.3: 15 residues within 4Å: Chain A: S.89, K.92 Chain C: S.62, T.63, R.64, T.65, R.113, H.141, Q.144, R.174, T.175, R.235, Q.237, P.273, M.274 22 PLIP interactions: 18 interactions with chain C, 4 interactions with chain A Hydrophobic interactions: C:T.175, C:P.273 Hydrogen bonds: C:S.62, C:S.62, C:T.63, C:R.64, C:R.64, C:T.65, C:T.65, C:R.113, C:R.113, C:Q.237, C:M.274, A:S.89 Water bridges: C:R.235, A:K.92 Salt bridges: C:R.113, C:H.141, C:R.174, C:R.235, A:K.92, A:K.92

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ruiz-Ramos, A. et al., Structure and Functional Characterization of Human Aspartate Transcarbamoylase, the Target of the Anti-Tumoral Drug Pala. Structure (2016)

Release Date

2016-06-22

Peptides

CAD PROTEIN: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

CAD PROTEIN

Related Entries With Identical Sequence